Fetal Bovine Serum Market will Accelerate at a CAGR of 5.44% due to Strategic Alliances Among Vendors - Technavio

Technavio offers in-depth market insights that assist global businesses to obtain growth opportunities. Read Free Sample Report

Fetal Bovine Serum Market Segmentation Highlights

• Application
• Biopharmaceuticals: The fetal bovine serum market share growth in the biopharmaceuticals segment will be significant during the forecast period. FBS, which contains altered active pharmaceutical ingredients with enhanced efficacy, will play a vital role in the development of biopharmaceuticals. This review highlights recent progress in the field of biopharmaceutical development and issues concerning the registration of innovative biopharmaceutical medicines. Such factors are expected to fuel the growth of the biopharmaceuticals segment during the forecast period.
• Human And Animal Vaccine
• Others
• Geography
• North America: 37% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the fetal bovine serum market in North America. Market growth in this region will be slower than the growth of the market in Europe and Asia. A rise in the number of clinical diagnostics businesses will facilitate the FBS market growth in North America over the forecast period. 
• Europe
• Asia
• Rest Of World (ROW)

Download Sample PDF for Segment-wise Contribution and Regional Opportunities

Fetal Bovine Serum Market Vendor Analysis 

The fetal bovine serum market is fragmented and the vendors are deploying growth strategies such as quality, price, brand, and reliability to compete in the market. This statistical study of the fetal bovine serum market encompasses successful business strategies deployed by the key vendors. 

To make the most of the opportunities and recover from the pandemic impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The fetal bovine serum market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Top Fetal Bovine Serum Market Players are:

• Anzco Foods Ltd: The company offers fetal bovine serum named Sterile Foetal Bovine Serum 500ml, through its subsidiary Bovogen Biologicals Pty Ltd
• Bio Techne Corp.: The company offers Fetal Bovine Serum - Premium Select of size 50ml, 100ml, and 500ml.
• BIOWEST SAS: The company offers fetal bovine serum, under the product code S1400 and S1580.
• Corning Inc.: The company offers fetal bovine serum named Corning Fetal Bovine Serum, 500 mL, Regular, USDA Approved Origin.
• Merck KGaA: The company offers fetal bovine serum, under catalog number TMS 016 B.
• HiMedia Laboratories Pvt. Ltd.
• Danaher Corp.
• GeminiBio
• Atlas Biologicals Inc.
• Axil Scientific Pte Ltd.
• Access Biologicals LLC
• Animal Technologies Inc.
• Moregate Biotech
• Nucleus Biologics
• PAN Biotech GmbH
• Peak Serum Inc.
• Rocky Mountain Biologicals LLC.
• Sartorius AG
• TCS Biosciences Ltd.
• Thermo Fisher Scientific Inc.
• Tissue Culture Biologicals

Want to know Vendor-specific Insights and Strategic initiatives? Download Sample Now!

The report also covers the following areas:

• Fetal Bovine Serum Market size
• Fetal Bovine Serum Market trends
• Fetal Bovine Serum Market industry analysis

Fetal Bovine Serum Market Highlights

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will assist fetal bovine serum market growth during the next five years
• Estimation of the fetal bovine serum market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the fetal bovine serum market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of fetal bovine serum market vendors

Related Reports:

Neonatal and Prenatal Devices Market in India by Product and End-user - Forecast and Analysis 2022-2026

Intrapartum Monitoring Devices Market by Product and Geography - Forecast and Analysis 2022-2026

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Biopharmaceuticals - Market size and forecast 2021-2026
• Exhibit 28: Chart on Biopharmaceuticals - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Biopharmaceuticals - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Biopharmaceuticals - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Biopharmaceuticals - Year-over-year growth 2021-2026 (%)

• 5.4 Human and animal vaccine - Market size and forecast 2021-2026
• Exhibit 32: Chart on Human and animal vaccine - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Human and animal vaccine - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Human and animal vaccine - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Human and animal vaccine - Year-over-year growth 2021-2026 (%)

• 5.5 Others - Market size and forecast 2021-2026
• Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Application
• Exhibit 40: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Denmark - Market size and forecast 2021-2026
• Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)

• 7.9 China - Market size and forecast 2021-2026
• Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.11 India - Market size and forecast 2021-2026
• Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification

• 10.3 Anzco Foods Ltd
• Exhibit 89: Anzco Foods Ltd - Overview
• Exhibit 90: Anzco Foods Ltd - Product / Service
• Exhibit 91: Anzco Foods Ltd - Key offerings

• 10.4 Bio Techne Corp.
• Exhibit 92: Bio Techne Corp. - Overview
• Exhibit 93: Bio Techne Corp. - Business segments
• Exhibit 94: Bio Techne Corp. - Key news
• Exhibit 95: Bio Techne Corp. - Key offerings
• Exhibit 96: Bio Techne Corp. - Segment focus

• 10.5 BIOWEST SAS
• Exhibit 97: BIOWEST SAS - Overview
• Exhibit 98: BIOWEST SAS - Product / Service
• Exhibit 99: BIOWEST SAS - Key offerings

• 10.6 Corning Inc.
• Exhibit 100: Corning Inc. - Overview
• Exhibit 101: Corning Inc. - Business segments
• Exhibit 102: Corning Inc. - Key offerings
• Exhibit 103: Corning Inc. - Segment focus

• 10.7 Merck KGaA
• Exhibit 104: Merck KGaA - Overview
• Exhibit 105: Merck KGaA - Business segments
• Exhibit 106: Merck KGaA - Key news
• Exhibit 107: Merck KGaA - Key offerings
• Exhibit 108: Merck KGaA - Segment focus

• 10.8 PAN Biotech GmbH
• Exhibit 109: PAN Biotech GmbH - Overview
• Exhibit 110: PAN Biotech GmbH - Product / Service
• Exhibit 111: PAN Biotech GmbH - Key offerings

• 10.9 Rocky Mountain Biologicals LLC.
• Exhibit 112: Rocky Mountain Biologicals LLC. - Overview
• Exhibit 113: Rocky Mountain Biologicals LLC. - Product / Service
• Exhibit 114: Rocky Mountain Biologicals LLC. - Key offerings

• 10.10 Sartorius AG
• Exhibit 115: Sartorius AG - Overview
• Exhibit 116: Sartorius AG - Business segments
• Exhibit 117: Sartorius AG - Key news
• Exhibit 118: Sartorius AG - Key offerings
• Exhibit 119: Sartorius AG - Segment focus

• 10.11 TCS Biosciences Ltd.
• Exhibit 120: TCS Biosciences Ltd. - Overview
• Exhibit 121: TCS Biosciences Ltd. - Product / Service
• Exhibit 122: TCS Biosciences Ltd. - Key offerings

• 10.12 Thermo Fisher Scientific Inc.
• Exhibit 123: Thermo Fisher Scientific Inc. - Overview
• Exhibit 124: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 125: Thermo Fisher Scientific Inc. - Key news
• Exhibit 126: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 127: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 128: Inclusions checklist
• Exhibit 129: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 130: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 131: Research methodology
• Exhibit 132: Validation techniques employed for market sizing
• Exhibit 133: Information sources

• 11.5 List of abbreviations
• Exhibit 134: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio